Shattuck Labs, Inc. (STTK)
NASDAQ: STTK · Real-Time Price · USD
6.50
-0.29 (-4.27%)
At close: Sep 8, 2026, 4:00 PM EDT
6.18
-0.61 (-8.98%)
After-hours: Sep 8, 2026, 7:31 PM EDT
Shattuck Labs Revenue
Shattuck Labs had revenue of $1.00M in the twelve months ending June 30, 2026, down -66.63% year-over-year. In the year 2025, Shattuck Labs had annual revenue of $1.00M, down -82.52%.
Revenue (ttm)
$1.00M
Revenue Growth
-66.63%
P/S Ratio
652.36
Revenue / Employee
$25,000
Employees
40
Market Cap
652.36M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.00M | -4.72M | -82.52% |
| Dec 31, 2024 | 5.72M | 4.06M | 245.26% |
| Dec 31, 2023 | 1.66M | 1.01M | 154.14% |
| Dec 31, 2022 | 652.00K | -29.37M | -97.83% |
| Dec 31, 2021 | 30.02M | 20.08M | 202.16% |
| Dec 31, 2020 | 9.93M | 47.00K | 0.48% |
| Dec 31, 2019 | 9.89M | -12.56M | -55.94% |
| Dec 31, 2018 | 22.44M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| CorMedix | 462.25M |
| MiMedx Group | 355.17M |
| Valneva SE | 163.30M |
| OmniAb | 38.46M |
| Allogene Therapeutics | 4.64M |
| Prime Medicine | 4.07M |
| ProKidney | 818.00K |
| Altimmune | 31.00K |
STTK News
- 22 hours ago - Shattuck Labs Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 6 days ago - Shattuck Labs Announces Participation in Upcoming September Investor Conferences - GlobeNewsWire
- 16 days ago - Shattuck Labs initiated with a Strong Buy at Raymond James - TheFly
- 4 weeks ago - Shattuck Labs price target lowered to $14 from $18 at H.C. Wainwright - TheFly
- 4 weeks ago - Shattuck Labs Quarterly report: Q2 2026 - Filings
- 4 weeks ago - Shattuck Labs Earnings release: Q2 2026 - Filings
- 4 weeks ago - Shattuck Labs Slides: Corporate presentation - Filings
- 4 weeks ago - Shattuck Labs reports Q2 EPS (12c), consensus (12c) - TheFly